POST-COVID SEQUELAE: THE BUMMOCK OF COVID ICEBERG
DOI:
https://doi.org/10.22159/ajpcr.2022.v15i12.44515Keywords:
Coronavirus, Polymerase chain reaction, COVID-19, Functional status, Comorbidity, FatigueAbstract
Objective: Coronavirus disease of 2019 (COVID-19) is a highly transmissible and pathogenic infection caused by severe acute respiratory syndrome, which resulted in a global pandemic and a significant loss of human life. The newer variants of concern are evolving even with the broadening vaccine immunity. Much of the clinical course remains uncertain especially the possible long-term health consequences. It is observed that there is an inter-individual variability in the occurrence of these post-COVID symptoms.
Methods: A prospective observational survey was conducted to demonstrate the post-COVID-19 manifestations and to identify if there is any association of these manifestations with the disease severity and presence of comorbidities.
Results: About 85% of our study subjects reported post-COVID manifestations of varying degrees. Fatigue was the most common post-COVID manifestation reporting to 56.36%. This was followed by body ache (43.3%) and myalgia (36.81%). The least observed manifestations were myocarditis (1.81%), heart attack (1.36%), and vomiting (1.36%).
Conclusion: An association between the severity of COVID disease and comorbidities was identified. The surface plot graph signified the existence of a positive association between the post-COVID manifestations with the severity of disease and the presence of comorbidities. The functional outcomes of the subjects after recovery were assessed using a post-COVID functional status scale.
Downloads
References
Fauci AS, Lane HC, Redfield RR. Covid-19-navigating the uncharted. N Engl J Med 2020;382:1268-9. doi: 10.1056/NEJMe2002387, PMID 32109011
Uvais NA, Moideen S, Hafi B, Rajagopal S, Maheshwari V, Gafoor TA. Insomnia among active patients with COVID-19: A cross-sectional study. Chronobiol Med 2021;3:31-4. doi: 10.33069/cim.2021.0002
Lovato A, De Filippis C. Clinical presentation of COVID-19: A systematic review focusing on upper airway symptoms. Ear Nose Throat J 2020;99:569-76. doi: 10.1177/0145561320920762, PMID 32283980
Hui KP, Cheung MC, Perera RA, Ng KC, Bui CH, Ho JC, et al. Tropism, replication competence, and innate immune responses of the coronavirus SARS-CoV-2 in human respiratory tract and conjunctiva: An analysis in ex-vivo and in-vitro cultures. Lancet Respir Med 2020;8:687-95. doi: 10.1016/S2213-2600(20)30193-4, PMID 32386571
Leap J, Villgran V, Cheema T. COVID-19: Epidemiology, pathophysiology, transmission, symptoms. Crit Care Nurs Q 2020;43:338-42. doi: 10.1097/CNQ.0000000000000319
Falzone L, Gattuso G, Tsatsakis A, Spandidos DA, Libra M. Current and innovative methods for the diagnosis of COVID-19 infection (Review). Int J Mol Med 2021;47:100. doi: 10.3892/ijmm.2021.4933, PMID 33846767
Zhai P, Ding Y, Wu X, Long J, Zhong Y, Li Y. The epidemiology, diagnosis and treatment of COVID-19. Int J Antimicrob Agents 2020;55:105955. doi: 10.1016/j.ijantimicag.2020.105955, PMID 32234468
Krammer F. SARS-CoV-2 vaccines in development. Nature 2020;586:516-27. doi: 10.1038/s41586-020-2798-3, PMID 32967006
Park KS, Sun X, Aikins ME, Moon JJ. Non-viral COVID-19 vaccine delivery systems. Adv Drug Deliv Rev 2021;169:137-51. doi: 10.1016/j. addr.2020.12.008, PMID 33340620
Mahmud R, Rahman MM, Rassel MA, Monayem FB, Sayeed SK, Islam MS, et al. Post-COVID-19 syndrome among symptomatic COVID-19 patients: A prospective cohort study in a tertiary care center of Bangladesh. PLOS One 2021;16:e0249644. doi: 10.1371/journal. pone.0249644, PMID 33831043
Kamal M, Abo Omirah M, Hussein A, Saeed H. Assessment and characterisation of post-COVID-19 manifestations. Int J Clin Pract 2021;75:e13746. doi: 10.1111/ijcp.13746, PMID 32991035
Klok FA, Boon GJ, Barco S, Endres M, Geelhoed JJ, Knauss S, et al. The post-COVID-19 functional status scale: A tool to measure functional status over time after COVID-19. Eur Respir J 2020;56:2001494. doi: 10.1183/13993003.01494-2020, PMID 32398306
World Health Organization. Clinical management of COVID-19 (Interim Guidance); Published May 27, 2020. Geneva: World Health Organization; 2020. Available from: https://www.who.int/ publications-detail/clinicalmanagement-of-covid-19 [Last accessed on 2021 Nov 23].
Carfì A, Bernabei R, Landi F, Gemelli Against COVID-19 Post- Acute Care Study Group. Persistent symptoms in patients after acute COVID-19. JAMA 2020;324:603-5. doi: 10.1001/jama.2020.12603
Xiong Q, Xu M, Li J, Liu Y, Zhang J, Xu Y, et al. Clinical sequelae of COVID-19 survivors in Wuhan, China: A single-centre longitudinal study. Clin Microbiol Infect 2021;27:89-95. doi: 10.1016/j. cmi.2020.09.023, PMID 32979574
Goërtz YM, Van Herck M, Delbressine JM, Vaes AW, Meys R, Machado FV, et al. Persistent symptoms 3 months after a SARS-CoV-2 infection: The post-COVID-19 syndrome? ERJ Open Res 2020;6:00542-2020. doi: 10.1183/23120541.00542-2020, PMID 33257910
Steardo L Jr., Steardo L, Verkhratsky A. Psychiatric face of COVID-19. Transl Psychiatry 2020;10:261.
Sher L. Are COVID-19 survivors at increased risk for suicide? Acta Neuropsychiatr 2020;32:270. doi: 10.1017/neu.2020.21, PMID 32364491
Cénat JM, Blais-Rochette C, Kokou-Kpolou CK, Noorishad PG, Mukunzi JN, McIntee SE, et al. Prevalence of symptoms of depression, anxiety, insomnia, posttraumatic stress disorder, and psychological distress among populations affected by the COVID-19 pandemic: A systematic review and meta-analysis. Psychiatry Res 2021;295:113599. doi: 10.1016/j.psychres.2020.113599, PMID 33285346
Taquet M, Geddes JR, Husain M, Luciano S, Harrison PJ. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: A retrospective cohort study using electronic health records. Lancet Psychiatry 2021;8:416-27. doi: 10.1016/S2215- 0366(21)00084-5, PMID 33836148
Silva Andrade B, Siqueira S, Soares WR, Rangel FD, Santos NO, Freitas AD, et al. Long-COVID and post-COVID health complications: An up-to-date review on clinical conditions and their possible molecular mechanisms. Viruses 2021;13:700. doi: 10.3390/v13040700, PMID 33919537
Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, et al. 6-month consequences of COVID-19 in patients discharged from hospital: A cohort study. Lancet 2021;397:220-32. doi: 10.1016/S0140- 6736(20)32656-8, PMID 33428867
Taquet M, Dercon Q, Luciano S, Geddes JR, Husain M, Harrison PJ. Incidence, co-occurrence, and evolution of long-COVID features: A 6-month retrospective cohort study of 273,618 survivors of COVID-19. PLoS Med 2021;18:e1003773. doi: 10.1371/journal. pmed.1003773, PMID 34582441
Sykes DL, Holdsworth L, Jawad N, Gunasekera P, Morice AH, Crooks MG. Post-COVID-19 symptom burden: What is long-COVID and how should we manage it? Lung 2021;199:113-9. doi: 10.1007/s00408-021- 00423-z, PMID 33569660
Tenforde MW, Kim SS, Lindsell CJ, Rose EB, Shapiro NI, Files DC, et al. Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network-United States, March-June 2020. MMWR Morb Mortal Wkly Rep 2020;69:993-8. doi: 10.15585/mmwr.mm6930e1, PMID 32730238
Published
How to Cite
Issue
Section
Copyright (c) 2022 MOHANRAJ K. P, ASNEEM K. M, MERIN CHERIAN, NAHID, YASAR ARAFATH S
This work is licensed under a Creative Commons Attribution 4.0 International License.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.
